Cyrus L Harmon

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 2

Top Topics

Positive Breast Cancer

Estrogen Receptor

Endoplasmic Reticulum

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, Fabian E Ortega, Guadalupe Peña, Judevin Sapugay, Brandon Robello, Richard Sun, David Kulp, Gopinath S Palanisamy, David C Myles, Peter J Kushner, Cyrus L Harmon
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination. Molecular cancer therapeutics 23 (3) (2024)
Alison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, Fabian E Ortega, Guadalupe Peña, Judevin Sapugay, Brandon Robello, Richard Sun, David Kulp, Gopinath S Palanisamy, David C Myles, Peter J Kushner, Cyrus L Harmon
Palazestrant (OP-1250), a Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination. Molecular cancer therapeutics (2023)